ANTH
Anthera Pharmaceuticals, Inc.
ANTH
ANTH
Delisted
ANTH was delisted on the 27th of June, 2018.
60 hedge funds and large institutions have $11.1M invested in Anthera Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
88% less call options, than puts
Call options by funds: $12K | Put options by funds: $102K
Holders
60
Holding in Top 10
–
Calls
$12K
Puts
$102K
Top Buyers
| 1 | +$3.4M | |
| 2 | +$1.23M | |
| 3 | +$709K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$391K |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$390K |
Top Sellers
| 1 | -$1.19M | |
| 2 | -$1.17M | |
| 3 | -$119K | |
| 4 |
RFCA
R&F Capital Advisors
New York
|
-$111K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$99.5K |